Jiangsu Nhwa Pharmaceutical Co., LTD (SHE:002262)
China · Delayed Price · Currency is CNY 22.72
+0.48 (2.16%)
Apr 8, 2026, 3:04 PM CST
SHE:002262 Revenue
Jiangsu Nhwa Pharmaceutical Co., LTD had revenue of 1.46B CNY in the quarter ending September 30, 2025, with 5.70% growth. This brings the company's revenue in the last twelve months to 6.02B, up 8.90% year-over-year. In the year 2024, Jiangsu Nhwa Pharmaceutical Co., LTD had annual revenue of 5.70B with 13.01% growth.
Revenue (ttm)
6.02B
Revenue Growth
+8.90%
P/S Ratio
3.75
Revenue / Employee
1.02M
Employees
5,923
Market Cap
22.59B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 5.70B | 656.13M | 13.01% |
| Dec 31, 2023 | 5.04B | 742.99M | 17.28% |
| Jan 1, 2023 | 4.30B | 362.85M | 9.22% |
| Jan 1, 2022 | 3.94B | 574.36M | 17.09% |
| Dec 31, 2020 | 3.36B | -788.01M | -18.99% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Revenue RankingsJiangsu Nhwa Pharmaceutical Co., LTD News
- 3 months ago - Luye Pharma Grants Nhwa Rights To Commercialize Three LAI Antipsychotics In Chinese Mainland - Nasdaq